Thrombolytic therapy in acute myocardial infarction

被引:15
作者
Huber, K
Maurer, G
机构
[1] Department of Cardiology, University of Vienna
[2] Department of Cardiology, University of Vienna, A-1090 Vienna
关键词
myocardial infarction; thrombolytic therapy; rt-PA; streptokinase; APSAC;
D O I
10.1055/s-2007-998988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite major advances made over the last decade, mortality following acute myocardial infarction (MI) is still high even for patients treated with the ''front-loaded'' recombinant tissue-type plasminogen activator (rt-PA) regimen: 30-day mortality is 6.3%, and it is associated with fatal cerebral hemorrhage in 1.5%. Further improvement of short- and long-term prognosis can be achieved if infusion of the thrombolytic agent starts early, if reperfusion occurs more rapidly, and if a persistent thrombolysis in myocardial infarction (TIMI) grade 3 flow of the infarct-related artery can be achieved. These are prerequisites for optimal preservation of ventricular function and predictors of a favorable outcome. New treatment strategies, e.g., more accelerated dosage regimens of established thrombolytic agents, new combination therapies, and new thrombolytic agents, with or without addition of more specific and more potent new antithrombotic agents, may further improve the efficacy of thrombolysis in acute MI during the late 1990s.
引用
收藏
页码:15 / 26
页数:12
相关论文
共 115 条
[1]   ANISTREPLASE VERSUS ALTEPLASE IN ACUTE MYOCARDIAL-INFARCTION - COMPARATIVE EFFECTS OF LEFT-VENTRICULAR FUNCTION, MORBIDITY AND 1-DAY CORONARY-ARTERY PATENCY [J].
ANDERSON, JL ;
BECKER, LC ;
SORENSEN, SG ;
KARAGOUNIS, LA ;
BROWNE, KF ;
SHAH, PK ;
MORRIS, DC ;
FINTEL, DJ ;
MUELLER, HS ;
ROSS, AM ;
HALL, SM ;
ASKINS, JC ;
DOOREY, AJ ;
GRINES, CL ;
MORENO, FL ;
MARDER, VJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (04) :753-766
[2]   MULTICENTER PATENCY TRIAL OF INTRAVENOUS ANISTREPLASE COMPARED WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
ANDERSON, JL ;
SORENSEN, SG ;
MORENO, FL ;
HACKWORTHY, RA ;
BROWNE, KF ;
DALE, HT ;
LEYA, F ;
DANGOISSE, V ;
ECKERSON, HW ;
MARDER, VJ .
CIRCULATION, 1991, 83 (01) :126-140
[3]   TIMI PERFUSION GRADE-3 BUT NOT GRADE-2 RESULTS IN IMPROVED OUTCOME AFTER THROMBOLYSIS FOR MYOCARDIAL-INFARCTION - VENTRICULOGRAPHIC, ENZYMATIC, AND ELECTROCARDIOGRAPHIC EVIDENCE FROM THE TEAM-3 STUDY [J].
ANDERSON, JL ;
KARAGOUNIS, LA ;
BECKER, LC ;
SORENSEN, SG ;
MENLOVE, RL .
CIRCULATION, 1993, 87 (06) :1829-1839
[4]  
[Anonymous], 1990, LANCET, V336, P65
[5]  
[Anonymous], 1988, LANCET, V2, P349
[6]  
[Anonymous], 1994, BMJ, V308, P159
[7]  
[Anonymous], 1993, Lancet, V342, P767
[8]   HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL [J].
ANTMAN, EM .
CIRCULATION, 1994, 90 (04) :1624-1630
[9]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[10]   RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND IMMEDIATE ANGIOPLASTY IN ACUTE MYOCARDIAL-INFARCTION - ONE-YEAR FOLLOW-UP [J].
ARNOLD, AER ;
SIMOONS, ML ;
VANDEWERF, F ;
DEBONO, DP ;
LUBSEN, J ;
TIJSSEN, JGP ;
SERRUYS, PW ;
VERSTRAETE, M .
CIRCULATION, 1992, 86 (01) :111-120